Fortress Biotech Revenue and Competitors

Location

$158.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Fortress Biotech's estimated annual revenue is currently $7.5M per year.(i)
  • Fortress Biotech's estimated revenue per employee is $288,462
  • Fortress Biotech's total funding is $158.7M.

Employee Data

  • Fortress Biotech has 26 Employees.(i)
  • Fortress Biotech grew their employee count by -4% last year.

Fortress Biotech's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
CEOReveal Email/Phone
3
General CounselReveal Email/Phone
4
VP, Business DevelopmentReveal Email/Phone
5
VP Business DevelopmentReveal Email/Phone
6
VP Finance & Corp Controller at Fortress BiotechReveal Email/Phone
7
VP Drug DiscoveryReveal Email/Phone
8
SVP Biologics OperationsReveal Email/Phone
9
Director Business DevelopmentReveal Email/Phone
10
Director Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is Fortress Biotech?

Coronado Biosciences is a clinical stage biopharmaceutical company focused on making cancer care better. How do we define better? We hope to make cancer care safer and more easily tolerated with improved outcomes. At Coronado Biosciences, we in-license promising therapies during late pre-clinical study and shepherd them through the drug development process. Our approach centers on refining identified product candidates and choosing therapeutic areas that allow for rapid progress from pharm/tox studies, through IND, and into proof-of-concept clinical trials. This model allows us to maximize product development opportunities, minimize potential risks associated with drug discovery, research, and earlier-stage activities, and maximize value inflections for investors. Our current drug candidates are based on related therapies with proven safety and biological activity in humans.

keywords:N/A

$158.7M

Total Funding

26

Number of Employees

$7.5M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fortress Biotech News

2022-04-20 - Fortress Biotech (NASDAQ:FBIO) Raised to “Hold” at ...

Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets...

2022-04-20 - Zacks: Brokerages Expect Fortress Biotech, Inc. (NASDAQ ...

Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets...

2022-04-17 - Fortress Biotech, Inc. (NASDAQ:FBIO) Receives Average ...

Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M26-51%$3M
#2
$4M26N/AN/A
#3
$1.8M26-10%$224M
#4
$1.8M260%$2.1M
#5
$2.6M26N/AN/A